Browsing by Author Krum, Henry

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
Issue DateTitleAuthor(s)Citation
2006Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.Coats, Andrew; Carvedilol, P o; Fowler, Michael B.; Katus, Hugo A.; Krum, Henry; Mohacsi, Paul; Packer, Milton; Roecker, Ellen B.; Rouleau, Jean-Lucien; Tendera, Michal; MedicineAre beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study., American Heart Journal, vol.151,(1),2006,pp 55-61
2006Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?Morel-Kopp, Marie-Christine; Tofler, Geoffrey; Aw, Tai-Juan; Billah, Baki; Krum, Henry; Liew, Danny; Schneider, Hans G.; Northern Clinical School: Medicine; Northern Clinical School: MedicineCan the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?, Journal of Hypertension, vol.24,(10),2006,pp 1979-1984
2017Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trialBillot, Laurent; Grover, Suchi; Hartshorne, Trent; Hillis, Graham; Jung, Werner; Krum, Henry; McGavigan, Andrew; Prasad, Sanjay; Selvanayagam, Joseph; The George Institute for Global HealthCardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial, Annals of Noninvasive Electrocardiology, vol.22, 4, 2017,pp 1-10
2015Design, Synthesis, and Biological Evaluation of Tetra-Substituted Thiophenes as Inhibitors of p38α MAPKMunoz, Lenka; Ryan, Renae; Chalmers, David; Devine, Shane; Krum, Henry; Scammells, Peter J.; Simpson, Jamie; Vinh, Natalie; Wang, Bing; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyDesign, Synthesis, and Biological Evaluation of Tetra-Substituted Thiophenes as Inhibitors of p38α MAPK, ChemistryOpen, vol.4, 1, 2015,pp 56-64
2002Does digitalis influence the response to beta-blockade in patients with severe chronic heart failure? Results of the COPERNICUS studyCoats, Andrew; Fowler, Michael B.; Katus, Hugo A.; Krum, Henry; Miller, Alan B.; Mohasci, Paul; O'Connor, Christopher; Packer, Milton; Roecker, Ellen B.; Rouleau, Jean-Lucien; Tendera, Michal; MedicineDoes digitalis influence the response to beta-blockade in patients with severe chronic heart failure? Results of the COPERNICUS study, Journal of the American College of Cardiology, vol.39,(Supplement 1),2002,pp 166A-166A
2002Does the degree of interference with the renin-angiotensin system influence the response to B-blockade in chronic heart failure? Results of the COPERNICUS studyCoats, Andrew; Mohacsi, Paula; Amann-Zalan, Ildiko; Fowler, Michael B.; Katus, Hugo A.; Krum, Henry; Packer, Milton; Roecker, Ellen B.; Rouleau, Jean-Lucien; Tendera, Michal; Medicine; Northern Clinical School: Molecular Medicine (Kolling I)Does the degree of interference with the renin-angiotensin system influence the response to B-blockade in chronic heart failure? Results of the COPERNICUS study, Journal of the American College of Cardiology, vol.39,(Supplement 1),2002,pp 167A-167A
2002Effect of gender on the outcome of patients with severe heart failure treated with carvedilol: Results of the COPERNICUS studyCoats, Andrew; Amann-Zalan, Ildiko; Fowler, Michael B.; Katus, Hugo A.; Krum, Henry; Mohacsi, Paul; Roecker, Ellen B.; Rouleau, Jean-Lucien; Shusterman, Neil H.; Tendera, Michal; MedicineEffect of gender on the outcome of patients with severe heart failure treated with carvedilol: Results of the COPERNICUS study, Journal of the American College of Cardiology, vol.39,(Supplement 1),2002,pp 185A-185A
2011Effects of Beta-adrenergic antagonists in patients with chronic kidney disease a systematic review and meta-analysisCass, Alan; Perkovic, Vlado; Badve, Sunil V.; Garg, Amit X.; Hawley, Carmel; Krum, Henry; Roberts, Matthew A.; Tonkin, Andrew; School of Public Health: Medicine; The George Institute for Global HealthEffects of Beta-adrenergic antagonists in patients with chronic kidney disease a systematic review and meta-analysis, Journal of the American College of Cardiology, vol.58, 11, 2011,pp 1152-1161
2002Efficacy and safety of carvedilol in patients with severe chronic heart failure and low systolic blood pressure: Results of the COPERNICUS studyCoats, Andrew; Amann-Zalan, Ildiko; Fowler, Michael B.; Holcslaw, Terry L.; Katus, Hugo A.; Krum, Henry; Mohacsi, Paul; Packer, Milton; Roecker, Ellen B.; Rouleau, Jean-Lucien; Tendera, Michal; MedicineEfficacy and safety of carvedilol in patients with severe chronic heart failure and low systolic blood pressure: Results of the COPERNICUS study, Journal of the American College of Cardiology, vol.39,(Supplement 1),2002,pp 171A-172A
2006Heart failure and nephropathy: Catastrophic and interrelated complications of diabetes.Pollock, Carol; Connelly, Kim; Gilbert, Richard E.; Kelly, Darren J.; Krum, Henry; Northern Clinical School: MedicineHeart failure and nephropathy: Catastrophic and interrelated complications of diabetes., Clinical Journal of the American Society of Nephrology, vol.1,(2),2006,pp 193-208
2004Influence Of Pretreatment Systolic Blood Pressure On The Effect Of Carvedilol In Patients With Severe Chronic Heart Failure: The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) StudyCoats, Andrew; Castaigne, Alain; et, al; Fowler, Michael B.; Katus, Hugo A.; Krum, Henry; Mohacsi, Paul; Roecker, Ellen B.; Rouleau, Jean-Lucien; Scherhag, Armin; Tendera, Michal; MedicineInfluence Of Pretreatment Systolic Blood Pressure On The Effect Of Carvedilol In Patients With Severe Chronic Heart Failure: The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) Study, Journal of the American College of Cardiology, vol.43,(8),2004,pp 1423-1429
2002Is additional neurohormonal antagonism useful in patients with severe chronic heart failure already receiving a combination of neurohormonal antagonists? Results of the COPERNICUS studyCoats, Andrew; Fowler, Michael B.; Katus, Hugo A.; Krum, Henry; Mohacsi, Paul; Packer, Milton; Roecker, Ellen B.; Rouleau, Jean L.; Tendera, Michal; MedicineIs additional neurohormonal antagonism useful in patients with severe chronic heart failure already receiving a combination of neurohormonal antagonists? Results of the COPERNICUS study, Journal of the American College of Cardiology, vol.39,(Supplement 1),2002,pp 177A-178A
2004Nt-Probnp In Severe Chronic Heart Failure: Rationale, Design And Preliminary Results Of The Copernicus Nt-Probnp SubstudyCoats, Andrew; Castaigne, Alain; et, al; Fowler, Michael B.; Hartmann, F.; Krum, Henry; Mohacsi, Paul; Packer, Milton; Rouleau, Jean-Lucien; Tendera, Michal; Trawinski, Juergen; MedicineNt-Probnp In Severe Chronic Heart Failure: Rationale, Design And Preliminary Results Of The Copernicus Nt-Probnp Substudy, European Journal of Heart Failure 2005, vol.6,(3),2004,pp 343-350
2002Plasma N-terminal pro-BNP predicts the occurrence of major clinical events in severe chronic heart failure: Results of a substudy of the COPERNICUS trialCoats, Andrew; Castaigne, Alain; et, al; Fowler, Michael B.; Hartmann, F.; Krum, Henry; Mohacsi, Paul; Packer, Milton; Richardt, Gert; Rouleau, Jean-Lucien; Tendera, Michal; MedicinePlasma N-terminal pro-BNP predicts the occurrence of major clinical events in severe chronic heart failure: Results of a substudy of the COPERNICUS trial, Journal of the American College of Cardiology, vol.39,(Supplement 1),2002,pp 200A-200A
2004Prognostic Impact Of Plasma N-Terminal Pro-Brain Natriuretic Peptide In Severe Chronic Congestive Heart Failure: A Substudy Of The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) TrialCoats, Andrew; Elder, James; et, al; Fowler, Michael B.; Hartmann, F.; Krum, Henry; Mohacsi, Paul; Packer, Milton; Rouleau, Jean L; Tendera, Michal; MedicinePrognostic Impact Of Plasma N-Terminal Pro-Brain Natriuretic Peptide In Severe Chronic Congestive Heart Failure: A Substudy Of The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) Trial, Circulation, vol.110,(13),2004,pp 1780-1786
2017Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic reviewAtkins, Emily; Bennett, Alexander; Chalmers, John; Chow, Clara Kayei; Hillis, Graham; Hilmer, Sarah; Neal, Bruce; Patel, Anushka; Peiris, David; Rodgers, Anthony; Rogers, Kris; Salam, Abdul; Thakkar, Jay; Usherwood, Timothy; Vo, Kha; Webster, Ruth; Woodward, Mark; Burke, Michael; Chou, M; Dehbi, Hakim-Moulay; Krum, Henry; Nelson, Mark; Reid, C; Thom, Simon; The George Institute for Global Health; Northern Clinical School: Pharmacology; The George Institute for Global Health; Western Clinical School: Medicine (Westmead); The George Institute for Global Health; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; School of Public Health: Public Health; The George Institute for Global Health; Childrens Hospital Westmead: Medicine; Western Clinical School: General Practice; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthQuarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review, The Lancet, vol.389, 10073, 2017,pp 1035-1042
2015The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility StudyPerkovic, Vlado; Badve, Sunil V.; Cass, Alan; Garg, Amit X.; Hawley, Carmel; Ierino, Francesco L.; Isbel, Nicole; Krum, Henry; Pascoe, Elaine; Pilmore, Helen; Roberts, Matthew A; Tonkin, Andrew M; Vergara, Liza A; The George Institute for Global HealthThe rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study, Nephrology, vol.20, 3, 2015,pp 140-147
2009The use of beta3-adrenergic receptor agonists in the treatment of heart failure.Figtree, Gemma; Rasmussen, Helge; Bundgaard, Henning; Krum, Henry; Northern Clinical School: Medicine; Northern Clinical School: MedicineThe use of beta3-adrenergic receptor agonists in the treatment of heart failure., Current Opinion in Investigational Drugs (Print), vol.10, 9,pp 955-962